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Abstract 
The heart has evolved elaborate pathways for adapting function to acute stress stimuli [e.g. 
sympathetic stimulation of β-adrenergic receptors (β-ARs)]. This “fight-or-flight” cardiac 
response to acute stress involves rapid changes in heart rate and contractility. However, β-
AR stimulation has been shown to enhance arrhythmogenesis due, in part, to induction of 
Ca2+ overload in cardiac myoctyes,1,2,3 although the precise mechanism remains unknown. 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated in response to β-
adrenergic stimulation and phosphorylates a myriad of intracellular targets including the 
cardiac sodium channel (Nav1.5) to alter myocyte excitability and Ca
2+ handling. Our 
group and others have shown that CaMKII-dependent phosphorylation of Nav1.5 at Ser571 
selectively regulates late sodium current (INa,L) in vivo. CaMKII-dependent increases in 
INa,L are linked to cardiac dysfunction.
4,5,18,19 We hypothesized that CaMKII-dependent 
phosphorylation of Nav1.5, and subsequent increases in INa,L, are essential for Ca
2+ handling 
defects and acute arrhythmic response to β-AR stimulation. Using optical mapping, we 
show that CaMKII-dependent phosphorylation of Nav1.5 alters Ca
2+ transients and 
arrhythmia susceptibility at baseline and in response to β-AR agonist isoproterenol. Our 
data demonstrate an important link between CaMKII-dependent phosphorylation of the 
Nav1.5 Ser571 site and Ca
2+ handling and arrhythmogenesis in response to acute β-AR 
stimulation. 
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Chapter 1. Introduction 
Background and Motivation 
The heart has inherent pacemaking abilities that enable it to establish its own rhythm, and 
it has developed elaborate pathways that enable it to alter this rhythm in response to 
changes in external stimuli. Specifically, sympathetic stimulation results in increased heart 
rate, contractility, conduction velocity, and relaxation rate, allowing the heart to adapt to 
the body’s increased oxygen requirements during acute stress. Of particular interest in this 
sympathetic system are β-adrenergic receptors, a subfamily of G-protein coupled receptors 
that have been closely linked to the development of heart failure (HF).6,7 β-adrenergic 
stimulation has been shown to magnify arrhythmogenesis during HF by inducing Ca2+ 
overload in cardiomyocytes.1,2,3 However, the mechanism by which this stimulation 
contributes to arrhythmogenesis is not fully understood. 
 
Previous studies have identified CaMKII as a serine/threonine-specific kinase that plays a 
critical role in cardiac excitation-contraction coupling and regulating ion homeostasis. 
Specifically, CaMKII has been shown to mediate “fight-or-flight” increases in heart rate 
by targeting regions of the heart responsible for Ca2+ homeostasis.8 Prior research has found 
that the active Ca2+/CaMKII complex phosphorylates the Ser571 site of the heart’s primary 
voltage-gated sodium channel, Nav1.5.
4 These channels are essential for cardiac 
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excitability and function, and their dysregulation can increase arrhythmia susceptibility and 
promote tissue remodeling. 
 
The Ser571 site, specifically, is responsible for regulating the persistent late sodium 
current, INa,L, without altering other channel properties that contribute to vital physiological 
components of the sodium current.5 This late component of the sodium current arises 
because at baseline conditions, a subset of sodium channels undergo failed or incomplete 
inactivation, allowing some sodium to continue to flow out of the cell, a phenomenon that 
has been directly linked with cardiac dysfunction and heightened arrhythmic 
susceptibility.5 Furthermore, CaMKII is activated following β-adrenergic stimulation, and 
CaMKII-dependent increases in INa,L have been linked to cardiac dysfunction in the form 
of Ca2+ mishandling and arrhythmogenesis.4,5 In addition to this, INa,L blockers like 
ranolazine have been shown to improve outcomes in patients with heart failure and atrial 
and ventricular arrhythmias, underscoring this action potential component’s role in 
arrhythmogenesis.18,19 
 
Although other groups have extensively examined the role of other channels—such as the 
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), ryanodine receptors (RyR2), and the 
sodium-calcium exchanger (NCX)—in arrhythmogenesis during β-adrenergic stimulation, 
much less is known about the role of INa,L.
10-16 Based on previous findings, it is likely that 
the interactions of CaMKII and INa,L play an important role in Ca
2+-handling and 
arrhythmogenesis specifically in the context of β-adrenergic stimulation. Thus, 
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understanding the exact mechanism by which CaMKII contributes to arrhythmogenesis 
during β-adrenergic stimulation may lead to novel therapies for the treatment of heart 
failure. A proposed mechanism is described in Figure 1 with the novel mechanistic 
components indicated in dark blue. The roles of structures like SERCA, RyR2, and NCX 
are simplified in this representation in order to emphasize the novel components involving 
the CaMKII/Nav1.5 axis acting simultaneously with isoproterenol-induced stimulation of 
β-adrenergic receptors.  
 
Figure 1: Hypothesized mechanism involved in cardiac Ca2+ handling and arrhythmogenesis during 
β-adrenergic stimulation. 
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Research Significance 
Cardiac arrhythmias pose a significant health risk, associated with many life-threatening 
conditions like sudden cardiac arrest, heart failure, and stroke. Ventricular tachycardia and 
ventricular fibrillation are specifically implicated in cardiac arrest, and of the 360,000 out-
of-hospital cases that occur each year in the United States, only 10-30% of patients survive 
to hospital discharge.9 Understanding the underlying mechanisms that contribute to 
arrhythmias is therefore critical for improving patient outcomes. This research project is 
important because it deepens our understanding of the role of CaMKII as a regulatory 
protein, especially as it relates to acute arrhythmogenesis at cellular and whole-heart levels. 
Furthermore, it advances our knowledge of the pathway through which β-AR agonists 
induce arrhythmias 
 
Based on the aforementioned findings, we hypothesized that CaMKII-dependent 
phosphorylation of the Nav1.5 Ser571 site, and subsequent increases in INa,L, are essential 
for Ca2+ handling defects and acute arrhythmic response during acute β-adrenergic 
stimulation.. Through this study, I hoped to determine whether Ca2+ overload resulting 
from β-AR stimulation leads to heightened levels of activated CaMKII and subsequent 
phosphorylation of Nav1.5, as well as to assess the extent to which this contributes to 
arrhythmogenesis at the whole-heart level. 
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Overview of Thesis 
The next chapter, Methodology, details the protocols used for optical mapping and western 
blotting experiments in this study. Chapter 3: Results provides an analysis of the results 
obtained from these experiments, including CaD80, tau, occurrence of PVCs, and levels of 
protein expression. The final chapter presents the major conclusions of the thesis project, 
details the author’s contributions to the study, projects future directions and additional 
applications of the techniques implemented in the study, and revisits the significance of the 
study’s results. 
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Chapter 2.  Methodology 
Animal Models 
Established strains of Scn5a knock-in mice that expressed either a phosphomimetic 
mutation at the Ser571 site of Nav1.5 (S571E) or that had the phosphorylation site ablated 
(S571A) were used for these studies.5 Experiments were performed in both male and 
female two- to six-month-old mice. Animals were anesthetized with isoflurane prior to 
tissue collection. All animal studies were performed in compliance with the Guide for the 
Care and Use of Laboratory Animals published by the National Institutes of Health 
following protocols that were reviewed and approved by the Institutional Animal Care and 
Use Committee at The Ohio State University. 
 
Optical Mapping 
Following isoflurane inhalation, hearts were rapidly excised and Langendorff-perfused 
with oxygenated modified Tyrode solution (140 mM NaCl, 1.0 mM MgCl2*6H2O, 1.2 mM 
NaH2PO4, 4.0 mM KCl, 1.8 mM CaCl2*H2O, 5.6 mM glucose, 10 mM HEPES) at 37°C 
and maintained at a pressure of 60-80 mmHg. Motion was reduced using 10 µM 
blebbistatin perfused for 15 minutes. Fluorescent rhod-2 (Biotium) was the Ca2+-sensitive 
dye used to measure calcium transients.1 The voltage-sensitive dye Rh-237 (Biotium) was 
also perfused in order to measure electrical activity, but it did not yield usable signals. 
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Following initial perfusion, hearts were transferred to a water bath maintained at 37°C and 
electrical activity was monitored using a continuously recorded volume-conducted bath 
electrocardiogram (ECG). A dual camera MICAM05 system was used to optically map the 
posterior epicardial surfaces of the ventricles during pacing with a unipolar electrode using 
an S1-S1 protocol with cycle lengths ranging from 40ms to 200ms. Slow pacing cycle 
lengths (i.e. 200 ms) were also used to induce early afterdepolarizations and associated 
ectopic activity in order to assess arrhythmogenesis. Hearts were mapped using the 
described protocol at baseline and after exposure to 150 nM isoproterenol (ISO), the drug 
used to stimulate the β-adrenergic receptors. 
 
Calcium transients were manually assessed using a custom-made Zeng Analysis 2015b 
MATLAB program. Specifically, the calcium-transient duration at 80% relaxation 
(CaD80) and the decay constant (tau) were examined. Additionally, arrhythmogenesis was 
assessed by examining the occurrence of premature ventricular contractions (PVCs). 
 
Western Blots 
Equal quantities of ventricular lysates (determined by standard bicinchoninic acid 
protocols) were analyzed via western blot. Equal protein loading was verified through 
Ponceau stains of blots, and differences in protein loading were corrected using 
normalization to GAPDH levels with Image Lab software and Excel. The following 
antibodies were used for western blotting: total CaMKII (Badrilla), p-CamKII (Thermo), 
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Nav1.54, Serca2a (Thermo), ox-CaMKII (Millipore), p-PLB (Santa Cruz), PLB (Abcam), 
and GAPDH (Fitzgerald). 
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Chapter 3.  Results and Discussion 
When normalized to total protein content, ox-CaMKII expression was decreased in S571A 
mice relative to WT mice (Figure 2). This suggests that S571A hearts exhibit lower levels 
of activated CaMKII, which might contribute to their tendency to be less arrhythmogenic 
at baseline. Interestingly, there did not initially seem to be large differences in levels of p-
CaMKII and p-PLB expression between the groups. This may be because the isoproterenol 
concentration used was causing such large Ca2+ overload that it obscured the differences 
between the groups. However, the number of replicates examined via western blot needs 
to be increased in order to draw any conclusions about statistical significance. 
 
Figure 2: Representative western blots for expression of oxidized and phosphorylated CaMKII at 
baseline and with isoproterenol. 
In addition to normalizing protein expression to total protein content, ox-CaMKII and p-
CaMKII levels were normalized to total CaMKII levels, and p-PLB levels were normalized 
to total PLB. This was done in order to determine how the phosphorylation state of each 
protein changes with the introduction of isoproterenol. As expected, the amount of 
10 
 
phosphorylated CaMKII increased when exposed to isoproterenol, confirming that there 
was more activated CaMKII available to phosphorylate Nav1.5 (Figure 2).  
 
During optical mapping experiments, it became clear that CaMKII-dependent 
phosphorylation of Nav1.5 alters CaD80 at baseline, as S571E mice exhibited significantly 
longer CaD80’s than both WT and S571A. This is illustrated by representative calcium 
transient traces from WT, S571E, and S571A ventricles at baseline conditions, as shown 
in Figure 3a. Summaries of the average CaD80 for all mouse models further illustrate that 
under baseline conditions, S571E mice have significantly elongated calcium transients 
compared to WT or S571A mice (Figure 3b, *p<0.05 vs. WT, #p<0.05 vs. S571A). 
 
Figure 3. CaMKII-dependent phosphorylation of Nav1.5 alters CaD80 at baseline. 
Interestingly, dosing these hearts with isoproterenol mitigated differences between S571E 
and WT, as the average CaD80 for mice in these two groups are virtually indistinguishable 
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(Figure 4). However, S571A mice appeared to exhibit some resistance to the effects of the 
drug. Although calcium transients experienced by these mice seemed to be slightly 
shortened as a result of isoproterenol, they were still significantly longer than transients 
from the other two groups (Figure 4, *p<0.05 vs. WT, #p<0.05 vs. S571E). 
 
Figure 4. CaMKII-dependent phosphorylation of Nav1.5 alters CaD80 with isoproterenol. 
Mirroring the results observed with CaD80, S571E mice exhibited significantly longer 
decay constants (tau) than WT mice at baseline, suggesting that CaMKII-dependent 
phosphorylation of Nav1.5 plays an important role in altering tau at baseline (Figure 5, 
*p<0.05 vs. WT). The differences in decay constant for S571E and S571A mice are not 
significant, though at baseline S571E mice tend to have longer decay constants than S571A 
mice. However, the number of replicates examined would need to be increased in order to 
confirm whether this difference is significant. 
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Figure 5. CaMKII-dependent phosphorylation of Nav1.5 alters tau at baseline. 
Further echoing the effects of CaMKII-dependent phosphorylation of Nav1.5 on CaD80, 
isoproterenol reduced tau for all mouse models. Like with CaD80, S571A mice exhibited 
resistance to the effects of isoproterenol, and even though they experienced a reduction in 
tau, they were still significantly longer than tau for S571E mice (Figure 6, #p<0.05 vs. 
S571E). Though the decay constant with isoproterenol for S571A hearts seems to be 
slightly longer than the decay constant for WT hearts, the number of replicates need to be 
increased in order to draw conclusions about whether this difference is significant. 
 
Figure 6. CaMKII-dependent phosphorylation of Nav1.5 alters tau with isoproterenol. 
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Connecting the examined differences to arrhythmogenic phenotypes, the study also 
examined incidence of premature ventricular contractions, or PVCs, for all three mouse 
models at baseline. Representative ECGs from WT, S571E, and S571A hearts demonstrate 
that under baseline conditions, S571E mice exhibit increased induction of PVCs compared 
to the other mouse models (Figure 7a). This is further confirmed by examining the number 
of mice that experienced 3 or more PVCs in the 5 minutes prior to pacing under control 
conditions. As can be seen in Figure 6b, S571E mice were more arrhythmogenic than 
S571A mice. 
 
Figure 7. CaMKII-dependent phosphorylation of Nav1.5 alters arrhythmogenesis at baseline. 
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Chapter 4. Conclusions 
Contributions 
Although CaD80 was prolonged in S571E mice relative to WT or S571A mice at baseline, 
isoproterenol eliminated these differences between S571E and WT mice. As expected, 
isoproterenol shortened CaD80 for all mouse models, although S571A hearts seemed to be 
resistant to CaD80 shortening in the presence of isoproterenol. As has been demonstrated 
previously, S571E hearts experienced more PVCs than WT or S571A mice before exposure 
to isoproterenol. Overall, these data demonstrate that CaMKII-dependent phosphorylation 
of the Nav1.5 Ser571 site is integral in Ca
2+ handling and arrhythmogenesis with and 
without β-adrenergic stimulation. Furthermore, this study suggests that the CaMKII/Nav1.5 
axis is a potential therapeutic target for patients that are vulnerable to sympathetically 
induced Ca2+ mishandling and arrhythmogenesis. 
 
Additional Applications and Future Work 
Although this study identified a key axis involved in arrhythmogenesis during β-adrenergic 
stimulation, much is still unknown about the precise mechanism involved. Future studies 
should thus explore the role of other potential players in causing Ca2+ mishandling and 
arrhythmias in these conditions. Specifically, a selection of ion channel blockers and/or 
inhibitors should be employed with and without β-adrenergic stimulation in order to 
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confirm actions of ion channels such as the L-type Ca2+ channel, NCX, SERCA, and RyR 
in the mouse models used in this study. Additionally, the number of replicates used for 
western blotting experiments should be increased in order to form a clearer picture of how 
various proteins are expressed. Patch-clamping experiments should be employed to 
determine whether the Ca2+-handling trends observed on a whole-ventricle level are also 
achieved in single cardiomyocytes. 
 
Summary 
Despite recent therapeutic advances, heart disease remains the leading cause of death in 
the United States.9 In the majority of cases, patients succumb to an electrical dysfunction, 
commonly referred to as an arrhythmia. Certain populations are especially vulnerable to 
arrhythmias during β-adrenergic stimulation, a type of signaling involved in acute stress. 
In order to develop more effective treatments for these patients, it is imperative that we 
understand the underlying cellular mechanisms that contribute to acute arrhythmogenesis. 
Through this study, we have identified CaMKII-dependent phosphorylation of the Nav1.5 
Ser571 site, as well as resulting increases in INa,L, as crucial contributors to Ca
2+ handling 
and arrhythmogenesis both with and without β-adrenergic stimulation. As future studies 
seek to confirm how the late current affects other structures during these conditions, the 
CaMKII/Nav1.5 axis provides a promising therapeutic target that can be harnessed to help 
patients with conditions that make them more susceptible to sympathetically induced 
cardiac dysfunction. 
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